AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Nasal Calcitonin Reduces Bone Loss By Over 40%.
2001 NOV 8 - (NewsRx.com & NewsRx.net) -- Unigene Laboratories, Inc. (UGNE) reported that the analysis of the data from the pivotal clinical trials for its proprietary nasal calcitonin spray showed a rapid and persistent reduction in bone loss as measured by several accepted blood markers.
The results of the study were presented at the October 2001, annual meeting of the American Society for Bone and Mineral Research in Phoenix, Arizona.
A substance in the bloodstream which measures the rate of bone loss in the tested subjects decreased by an average of over 40% in the first month of the study, and that reduction was maintained throughout the three-month dosing period during which the measurements were taken. All other blood markers of bone ...
- Nasal Calcitonin Reduces Bone Loss By Over 40%.
- Newspaper article from: Drug Week November 9, 2001 700+ words
...its proprietary nasal calcitonin spray showed...reduction in bone loss as measured by...measures the rate of bone loss in the tested...blood markers of bone loss that were measured...observed for our nasal calcitonin product and we...
- Unigene Reports Success of Nasal Calcitonin Clinical Study - Primary Marker of...
- Press release article from: PR Newswire October 9, 2001 700+ words
...its proprietary nasal calcitonin spray showed...reduction in bone loss as measured by...measures the rate of bone loss in the tested...blood markers of bone loss that were measured...observed for our nasal calcitonin product and we...
- Unigene Licenses Its Nasal Calcitonin Osteoporosis Product in Greece; Faran...
- Press release article from: Business Wire September 23, 2003 700+ words
...exclusive license in Greece for its nasal calcitonin osteoporosis product to Faran Laboratories...grant the same indications to all nasal calcitonin products, the success of each product...licensed the U.S. rights for its nasal calcitonin product to Upsher-Smith Laboratories...
- Unigene Reports Successful Conclusion of Nasal Calcitonin Clinical Study.
- Press release article from: PR Newswire December 18, 2000 700+ words
...completed a clinical study for its nasal calcitonin product demonstrating equivalent bioavailability...formulation and that of an existing nasal calcitonin product. A second clinical study...a significant achievement for our nasal calcitonin program and for the Company in general...
- In a New Observational Analysis, Risedronate Significantly Reduced Nonvertebral...
- Press release article from: PR Newswire September 22, 2003 700+ words
...lower risk than patients receiving nasal calcitonin, at one year of treatment. "Fracture...mg daily or 35/70 mg weekly) or nasal calcitonin (200 I.U. daily), between July...six months for a bisphosphonate, nasal calcitonin or raloxifene were excluded. All...
- Unigene Announces U.S. Patent Issuance For Nasal Calcitonin Product For...
- Press release article from: Business Wire September 10, 2002 700+ words
...into the bloodstream. A third party nasal calcitonin product is a leading treatment for...position for the commercialization of our nasal calcitonin product," commented Dr. Warren...New Drug Application (NDA) for its nasal calcitonin product later this year. About Unigene...
- NDA filed for Fortical, nasal calcitonin product.
- Newspaper article from: Drug Week April 4, 2003 700+ words
...Administration (FDA) for Fortical, its patented formulation of nasal calcitonin. As Unigene's exclusive U.S. licensing partner...formulation was issued in 2002. The current U.S. market for nasal calcitonin is approximately $275 million. Recent third party studies...
- Unigene's NDA for Injectable and Nasal Calcitonin Products for Osteoporosis...
- Press release article from: Business Wire September 4, 2003 700+ words
...new drug application (NDA) covering its injectable and nasal calcitonin products for osteoporosis has been filed in China. The...therapies. Unigene has licensed the U.S. rights for its nasal calcitonin product to Upsher-Smith Laboratories and the worldwide...